Healthcare provider profile · identity verified

Anu Rose Antony

Nurse Practitioner · ROUND ROCK, TX · NPI 1780132886

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	492	55
Gabapentin	Gabapentin	397	36
Eliquis	Apixaban	293	23
Furosemide	Furosemide	276	38
Donepezil Hcl	Donepezil Hcl	264	25
Amlodipine Besylate	Amlodipine Besylate	240	29
Lisinopril	Lisinopril	227	26
Levothyroxine Sodium	Levothyroxine Sodium	213	29
Divalproex Sodium	Divalproex Sodium	181	24
Sertraline Hcl	Sertraline Hcl	169	19
Metoprolol Tartrate	Metoprolol Tartrate	165	23
Escitalopram Oxalate	Escitalopram Oxalate	164	25
Levetiracetam	Levetiracetam	163	18
Trazodone Hcl	Trazodone Hcl	162	19
Memantine Hcl	Memantine Hcl	159	14
Metformin Hcl	Metformin Hcl	156	22
Potassium Chloride	Potassium Chloride	150	29
Pantoprazole Sodium	Pantoprazole Sodium	140	25
Losartan Potassium	Losartan Potassium	138	15
Tamsulosin Hcl	Tamsulosin Hcl	132	17
Carvedilol	Carvedilol	106	13
Clopidogrel	Clopidogrel Bisulfate	92	12
Mirtazapine	Mirtazapine	90	18
Duloxetine Hcl	Duloxetine Hcl	83	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	83	13
Baclofen	Baclofen	82	suppressed
Finasteride	Finasteride	82	11
Metoprolol Succinate	Metoprolol Succinate	82	12
Montelukast Sodium	Montelukast Sodium	82	suppressed
Glipizide	Glipizide	76	suppressed
Myrbetriq	Mirabegron	70	suppressed
Jardiance	Empagliflozin	68	suppressed
Buspirone Hcl	Buspirone Hcl	66	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	65	suppressed
Ondansetron Hcl	Ondansetron Hcl	65	25
Celecoxib	Celecoxib	62	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	59	17
Famotidine	Famotidine	57	14
Hydrochlorothiazide	Hydrochlorothiazide	55	suppressed
Meloxicam	Meloxicam	55	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	53	12
Xarelto	Rivaroxaban	52	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	51	19
Allopurinol	Allopurinol	50	suppressed
Methocarbamol	Methocarbamol	50	11
Alendronate Sodium	Alendronate Sodium	45	suppressed
Simvastatin	Simvastatin	45	suppressed
Tizanidine Hcl	Tizanidine Hcl	44	suppressed
Oxcarbazepine	Oxcarbazepine	42	suppressed
Hydralazine Hcl	Hydralazine Hcl	39	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	39	suppressed
Trulicity	Dulaglutide	36	suppressed
Citalopram Hbr	Citalopram Hydrobromide	35	suppressed
Humalog	Insulin Lispro	35	suppressed
Lantus	Insulin Glargine,hum.Rec.Anlog	33	12
Spironolactone	Spironolactone	33	suppressed
Amiodarone Hcl	Amiodarone Hcl	32	suppressed
Bupropion Xl	Bupropion Hcl	31	suppressed
Januvia	Sitagliptin Phosphate	31	suppressed
Paroxetine Hcl	Paroxetine Hcl	31	suppressed
Prednisone	Prednisone	31	suppressed
Tramadol Hcl	Tramadol Hcl	30	suppressed
Folic Acid	Folic Acid	27	suppressed
Rosuvastatin Calcium	Rosuvastatin Calcium	27	suppressed
Topiramate	Topiramate	27	suppressed
Atenolol	Atenolol	26	suppressed
Latanoprost	Latanoprost	25	suppressed
Lorazepam	Lorazepam	25	suppressed
Rivastigmine	Rivastigmine	25	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	24	suppressed
Clindamycin Hcl	Clindamycin Hcl	24	suppressed
Rytary	Carbidopa/Levodopa	24	suppressed
Isosorbide Dinitrate	Isosorbide Dinitrate	23	suppressed
Nebivolol Hcl	Nebivolol Hcl	23	suppressed
Novolog	Insulin Aspart	23	suppressed
Propranolol Hcl	Propranolol Hcl	23	suppressed
Rivastigmine	Rivastigmine Tartrate	23	suppressed
Ropinirole Hcl	Ropinirole Hcl	22	suppressed
Carbidopa-Levodopa	Carbidopa/Levodopa	21	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	21	suppressed
Ipratropium-Albuterol	Ipratropium/Albuterol Sulfate	21	17
Lamotrigine	Lamotrigine	20	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	20	suppressed
Omeprazole	Omeprazole	20	suppressed
Quetiapine Fumarate Er	Quetiapine Fumarate	20	suppressed
Ibuprofen	Ibuprofen	19	suppressed
Breo Ellipta	Fluticasone/Vilanterol	18	suppressed
Brimonidine Tartrate-Timolol	Brimonidine Tartrate/Timolol	18	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	18	suppressed
Enalapril Maleate	Enalapril Maleate	18	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	18	suppressed
Solifenacin Succinate	Solifenacin Succinate	18	suppressed
Valsartan	Valsartan	18	suppressed
Amantadine	Amantadine Hcl	17	suppressed
Carbamazepine	Carbamazepine	17	suppressed
Methimazole	Methimazole	17	suppressed
Lactulose	Lactulose	16	suppressed
Trintellix	Vortioxetine Hydrobromide	16	suppressed
Vitamin D2	Ergocalciferol (Vitamin D2)	16	suppressed
Acetazolamide	Acetazolamide	15	suppressed
Bupropion Hcl Sr	Bupropion Hcl	15	suppressed
Farxiga	Dapagliflozin Propanediol	15	suppressed
Memantine Hcl Er	Memantine Hcl	15	suppressed
Levemir	Insulin Detemir	14	suppressed
Nystatin	Nystatin	14	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	14	suppressed
Rasagiline Mesylate	Rasagiline Mesylate	14	suppressed
Restasis Multidose	Cyclosporine	14	suppressed
Cephalexin	Cephalexin	13	suppressed
Cholestyramine	Cholestyramine (With Sugar)	13	suppressed
Ranolazine Er	Ranolazine	13	suppressed
Lurasidone Hcl	Lurasidone Hcl	12	suppressed
Phenytoin Sodium Extended	Phenytoin Sodium Extended	12	suppressed
Symbicort	Budesonide/Formoterol Fumarate	12	suppressed
Verapamil Er	Verapamil Hcl	12	suppressed
Carbamazepine Er	Carbamazepine	11	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	11	suppressed
Fluticasone Propionate	Fluticasone Propionate	11	suppressed
Insulin Lispro	Insulin Lispro	11	suppressed
Irbesartan	Irbesartan	11	suppressed
Lansoprazole	Lansoprazole	11	suppressed
Metformin Hcl Er	Metformin Hcl	11	suppressed
Midodrine Hcl	Midodrine Hcl	11	suppressed
Pravastatin Sodium	Pravastatin Sodium	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error